Extended Camera Ready Submission Deadline
Extended Regular/Author Registration Deadline
Opening Day of ICNFA'15
Vascular Nanomedicine (July 17):
Vascular system is the natural route for delivery of drug nanocarriers to therapeutic targets in the body and often represents a therapeutic site itself. Endothelial cells lining the vascular luminal surface represent the target, barrier or victim of circulating nanomedicine agents. We will discuss key aspects of design of nanomedicine agents, control of their cellular delivery and uptake and specific examples of preclinical studies of nanodevices for drug delivery for treatment diverse disease conditions including inflammation, oxidative stress, thrombosis and cancer.
Design of drug nanocarriers (July 17):
Injectible nanocarriers hold promise to improve drug delivery and thus, therapeutic outcomes by several mechanisms including more effective packaging of poorly soluble agents, protection of the drug from the body and vice versa, optimized pharmacokinetics, biodistribution and localization of the drug, and control of its release, activation, duration and elimination. Targeting to specific cellular compartments, control of intracellular delivery and trafficking of these nanocarriers and their biocompatibility all represent challenging and important aspects of design of candidate nanomedicine agents. This session will discuss these aspects with focus on interaction of nanocarriers with their targets.